Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
Veterans Affairs Center for Clinical Management Research, Ann Arbor, Michigan.
Am J Respir Crit Care Med. 2019 Oct 15;200(8):972-981. doi: 10.1164/rccm.201812-2383CP.
An estimated 14.1 million patients survive sepsis each year. Many survivors experience poor long-term outcomes, including new or worsened neuropsychological impairment; physical disability; and vulnerability to further health deterioration, including recurrent infection, cardiovascular events, and acute renal failure. However, clinical trials and guidelines have focused on shorter-term survival, so there are few data on promoting longer-term recovery. To address this unmet need, the International Sepsis Forum convened a colloquium in February 2018 titled "Understanding and Enhancing Sepsis Survivorship." The goals were to identify gaps and limitations of current research and shorter- and longer-term priorities for understanding and enhancing sepsis survivorship. Twenty-six experts from eight countries participated. The top short-term priorities identified by nominal group technique culminating in formal voting were to better leverage existing databases for research, develop and disseminate educational resources on postsepsis morbidity, and partner with sepsis survivors to define and achieve research priorities. The top longer-term priorities were to study mechanisms of long-term morbidity through large cohort studies with deep phenotyping, build a harmonized global sepsis registry to facilitate enrollment in cohorts and trials, and complete detailed longitudinal follow-up to characterize the diversity of recovery experiences. This perspective reviews colloquium discussions, the identified priorities, and current initiatives to address them.
每年估计有 1410 万患者幸存于脓毒症。许多幸存者经历不良的长期结局,包括新的或恶化的神经心理障碍、身体残疾;以及进一步健康恶化的易感性,包括复发性感染、心血管事件和急性肾衰竭。然而,临床试验和指南主要集中在短期生存上,因此,关于促进长期恢复的数据很少。为了解决这一未满足的需求,国际脓毒症论坛于 2018 年 2 月召开了一次专题讨论会,题为“理解和增强脓毒症幸存者的生存能力”。其目的是确定当前研究的差距和局限性,以及理解和增强脓毒症幸存者生存能力的短期和长期优先事项。来自 8 个国家的 26 名专家参加了会议。通过名义群体技术并最终进行正式投票确定的短期优先事项包括更好地利用现有数据库进行研究、开发和传播关于脓毒症后发病率的教育资源,并与脓毒症幸存者合作,确定和实现研究重点。长期优先事项是通过具有深度表型的大型队列研究来研究长期发病的机制,建立一个协调一致的全球脓毒症登记处,以促进队列和试验的入组,并完成详细的纵向随访,以描述恢复体验的多样性。本观点回顾了专题讨论会的讨论、确定的优先事项以及目前为解决这些问题而采取的举措。